Metrics to compare | BRAW | Peers Peers - average of corresponding metrics from companies closely matching BRAW: 530897, MAITREYA, 539378, MONOPHARMA, 526504 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBRAWPeersSector |
|---|---|---|---|---|
P/E Ratio | 7.9x | 59.5x | −0.4x | |
PEG Ratio | 0.04 | 0.54 | 0.00 | |
Price/Book | 1.6x | 1.2x | 2.6x | |
Price / LTM Sales | 0.4x | 4.7x | 3.0x | |
Upside (Analyst Target) | - | 12.9% | 48.7% | |
Fair Value Upside | Unlock | −5.6% | 7.0% | Unlock |
Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.